Vitamin D in prostate cancer

Clicks: 309
ID: 68582
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Signaling through the vitamin D receptor has been shown to be biologically active and important in a number of preclinical studies in prostate and other cancers. Epidemiologic data also indicate that vitamin D signaling may be important in the cause and prognosis of prostate and other cancers. These data indicate that perturbation of vitamin D signaling may be a target for the prevention and treatment of prostate cancer. Large studies of vitamin D supplementation will be required to determine whether these observations can be translated into prevention strategies. This paper reviews the available data in the use of vitamin D compounds in the treatment of prostate cancer. Clinical data are limited which support the use of vitamin D compounds in the management of men with prostate cancer. However, clinical trials guided by existing preclinical data are limited.
Reference Key
trump2018vitaminasian Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Trump, Donald L;Aragon-Ching, Jeanny B;
Journal asian journal of andrology
Year 2018
DOI
DOI not found
URL
http://www.ajandrology.com/article.asp?issn=1008-682X;year=2018;volume=20;issue=3;spage=244;epage=252;aulast=Trump
Keywords
Medicine Medical technology nutrition. foods and food supply diseases of the genitourinary system. urology specialties of internal medicine diseases of the digestive system. gastroenterology medical philosophy. medical ethics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.